---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-245614"
form_type: "8-K"
ticker: "TEVA"
cik: "0000818686"
company_name: "TEVA PHARMACEUTICAL INDUSTRIES LTD"
filed_at: "2023-09-28T23:59:59+00:00"
generated_at: "2026-06-10T07:57:18.733063+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Teva appoints Christine Fox as EVP U.S. Commercial; Sven Dethlefs departing Nov 17

## Summary
- Sven Dethlefs, EVP North America Commercial, to leave Teva on November 17, 2023 after 15 years.
- Christine Fox appointed EVP U.S. Commercial; previously Global President, Gene Therapies at Novartis.
- Fox brings 30+ years industry experience from Novartis, Amgen, Merck, Takeda.
- CEO Richard Francis thanked Dethlefs and expressed confidence in Fox's ability to lead U.S. business.

## SEC filing metadata
- accession: 0001193125-23-245614
- form_type: 8-K
- ticker: TEVA
- cik: 0000818686
- company_name: TEVA PHARMACEUTICAL INDUSTRIES LTD
- filed_at: 2023-09-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818686/000119312523245614/0001193125-23-245614-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818686/000119312523245614/d469125d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-245614
- JSON: https://secwatch.observer/filing/0001193125-23-245614.json
- Plain text: https://secwatch.observer/filing/0001193125-23-245614.txt

## Key facts
- Executive change
  Sven Dethlefs departed as Executive Vice President, North America Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD.
  - Action: leaving
  - Role: Executive Vice President, North America Commercial
  source text: Dr. Sven Dethlefs, Executive Vice President, North America Commercial, will be leaving Teva.
  evidence_url: https://www.sec.gov/Archives/edgar/data/818686/000119312523245614/0001193125-23-245614-index.htm
- Executive change
  Christine Fox was appointed as Executive Vice President, U.S. Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD.
  - Action: appointed
  - Role: Executive Vice President, U.S. Commercial
  source text: Ms. Christine Fox will be appointed as Executive Vice President, U.S. Commercial.
  evidence_url: https://www.sec.gov/Archives/edgar/data/818686/000119312523245614/0001193125-23-245614-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.